Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDPK2P (3-phosphoinositide dependent protein kinase 2, pseudogene) is a non-protein coding gene/Pseudogene that gives rise to a long noncoding RNA, lncRNA-PDPK2P, which is highly homologous to the functional kinase PDK1 but does not encode an active enzyme[2][1]. The transcript of PDPK2P acts as a competitive endogenous RNA, regulating cell proliferation, apoptosis, migration, and invasion, particularly in hepatocellular carcinoma, by interacting with PDK1 and modulating the PDK1/AKT/caspase signaling cascade[1]. This pseudogene is not a conventional protein target and is not referenced in major drug-interaction databases. Its altered expression is clinically associated with tumor progression and poor prognosis, and it is of interest mainly as a disease biomarker or possible regulatory mechanism in cancer biology[1].
None directly; lncRNA-PDPK2P regulates PDK1 function via RNA-RNA interaction and competitive endogenous RNA (ceRNA) mechanisms affecting the PDK1/AKT/caspase pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 3-phosphoinositide dependent protein kinase 2, pseudogene (PDPK2P).